Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 1,377,058 | 1,293,338 | 1,218,689 | 1,103,392 | 1,031,633 |
| Cost of Goods | 620,940 | 594,190 | 572,183 | 524,769 | 505,352 |
| Gross Profit | 756,118 | 699,148 | 646,506 | 578,623 | 526,281 |
| Operating Expenses | 490,296 | 436,775 | 410,464 | 375,511 | 350,664 |
| Operating Income | 266,762 | 262,563 | 236,225 | 203,881 | 175,969 |
| Interest Expense | 5,386 | 3,848 | 3,547 | 2,415 | 1,916 |
| Other Income | 1,885 | 1,902 | 1,744 | 663 | 486 |
| Pre-tax Income | 263,261 | 260,617 | 234,422 | 202,129 | 174,539 |
| Income Tax | 75,467 | 82,330 | 72,668 | 60,809 | 52,304 |
| Net Income Continuous | 187,794 | 178,287 | 161,754 | 141,320 | 122,235 |
| Minority Interests | -6 | 20 | -32 | 36 | 10 |
| Net Income | $187,800 | $178,267 | $161,786 | $141,284 | $122,225 |
| EPS Basic Total Ops | 1.77 | 1.62 | 1.43 | 1.23 | 1.04 |
| EPS Basic Continuous Ops | 1.77 | 1.62 | 1.42 | 1.22 | 1.04 |
| EPS Diluted Total Ops | 1.74 | 1.59 | 1.39 | 1.19 | 1.01 |
| EPS Diluted Continuous Ops | 1.74 | 1.59 | 1.39 | 1.19 | 1.01 |
| EBITDA(a) | $321,358 | $314,971 | $284,427 | $249,837 | $225,742 |